Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Kalinov (Krumovo, Bulgaria). Exercise desaturation in patients with COPD – potent  marker for more severe disease progression and prognosis. 2240

Member's Comments

No comment yet.

Related content which might interest you: Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Prognostic value of exercise testing Source: Annual Congress 2007 - PG12 - Cardiopulmonary exercise testing and interpretation Year: 2007 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Factors associated with improvement in breathing capacity during exercise in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Lung function reversibility as a predictor of disease progression in COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Exercise capacity predicts survival in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 488s Year: 2001 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD Year: 2021 Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease. Source: International Congress 2017 – COPD and weaning Year: 2017 Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 The most frequent comorbidies in COPD and their inflence on the prognosis of the disease Source: Annual Congress 2013 –COPD treatment and others Year: 2013